Shanghai Henlius Biotech, Inc. Class H(HK:2696)
HK$43.06-1.18 (-2.67%)
HK:2696
Shanghai Henlius Biotech, Inc. Class H financials statements
HK$43.06
At close:-1.18 (-2.67%)
Want to see HK:2696 full AI Analyst Report?
Shanghai Henlius Biotech, Inc. Class H (2696) Income Statement
8 Followers
Shanghai Henlius Biotech, Inc. Class H Income Statement
Last quarter (Q2 2026), Shanghai Henlius Biotech, Inc. Class H's total revenue was ¥1.79B, an increase of 27.26% from the same quarter last year. In Q2, Shanghai Henlius Biotech, Inc. Class H's net income was ¥215.22M. See Shanghai Henlius Biotech, Inc. Class H’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| ¥ 6.67B | ¥ 5.72B | ¥ 5.39B | ¥ 3.21B | ¥ 1.68B | |
| ¥ 4.98B | ¥ 4.18B | ¥ 3.92B | ¥ 2.37B | ¥ 1.16B | |
| ¥ 4.17B | ¥ 3.25B | ¥ 3.29B | ¥ 3.00B | ¥ 1.82B | |
| Depreciation and Amortization | ¥ 429.41M | ¥ 374.80M | ¥ 359.23M | ¥ 277.60M | ¥ 200.18M |
| ¥ 1.25B | ¥ 1.24B | ¥ 990.94M | ¥ -310.61M | ¥ -671.74M | |
| ¥ 817.12M | ¥ 939.13M | ¥ 631.70M | ¥ -628.53M | ¥ -665.25M | |
| ¥ -5.40M | ¥ -93.25M | ¥ -62.13M | ¥ -65.36M | ¥ -291.49M | |
| ¥ 811.72M | ¥ 845.88M | ¥ 569.58M | ¥ -693.89M | ¥ -956.74M | |
| ¥ 805.64M | ¥ 820.47M | ¥ 546.02M | ¥ -695.26M | ¥ -984.05M | |
| Per Share Metrics | |||||
| Basic EPS | ¥ 1.47 | ¥ 1.51 | ¥ 1.00 | ¥ -1.28 | ¥ -1.83 |
| Diluted EPS | ¥ 1.47 | ¥ 1.51 | ¥ 1.00 | ¥ -1.28 | ¥ -1.83 |
| Weighted Average Shares Outstanding | 545.93M | 543.49M | 543.37M | 542.02M | 537.73M |
| Weighted Average Shares Outstanding (Diluted) | 545.93M | 543.49M | 543.37M | 542.02M | 538.84M |
Currency in CNY
